Vitamin D Deficiency in Pregnancy: An Independent Risk Factor for Increased Maternal and Foetal Co-Morbidities
International Journal of Health Sciences and Research Vol.7; Issue: 2; February 2017. ISSN: 2249-9571, Accepted: 27/01/2017
|< 12.5 ng||> 20 ng||Odds Ratio|
|Apgar level <7||14.6%||1.3%|
|small for gestational age||25.6%||3.4%|
- Type II Diabetes in children in India increased 4 X in 20 years – Nov 2016
- Why India's vitamin D deficiency is grim - 40 pages Feb 2014
- Search VitaminDWiki for those items with INDIA in the title 33 items as of March 2017
- Vitamin D deficiency a big problem in Pakistan, similar to India – July 2016
- Farmers in India have 2.5 times higher vitamin D than office workers – 2016
- Majority of infant seizures in India due to lack of vitamin D - July 2010
- Overview Dark skin births and Vitamin D
World Health Organization continues to say ZERO vitamin D during pregnancy - 2016
Healthy pregnancies need lots of vitamin D has the following summary
|0. Chance of not conceiving||3.4 times||Observe|
|1. Miscarriage||2.5 times||Observe|
|2. Pre-eclampsia||3.6 times||RCT|
|3. Gestational Diabetes||3 times||RCT|
|4. Good 2nd trimester sleep quality||3.5 times||Observe|
|5. Premature birth||2 times||RCT|
|6. C-section - unplanned||1.6 times||Observe|
|Stillbirth - OMEGA-3||4 times||RCT - Omega-3|
|7. Depression AFTER pregnancy||1.4 times||RCT|
|8. Small for Gestational Age||1.6 times||meta-analysis|
|9. Infant height, weight, head size |
within normal limits
|10. Childhood Wheezing||1.3 times||RCT|
|11. Additional child is Autistic||4 times||Intervention|
|12.Young adult Multiple Sclerosis||1.9 times||Observe|
|13. Preeclampsia in young adult||3.5 times||RCT|
|14. Good motor skills @ age 3||1.4 times||Observe|
|15. Childhood Mite allergy||5 times||RCT|
|16. Childhood Respiratory Tract visits||2.5 times||RCT|
RCT = Randomized Controlled Trial
- Miscarriage 1.6 X more likely if low vitamin D – meta-analysis May 2022
- Recurrent Miscarriage 4X more likely if low vitamin D – meta-analysis June 2022
- Pregnancy problems (LBW, PTB, SGA) associated with low vitamin D, 42nd meta-analysis – March 2022
- Low Vitamin D associated with preeclampsia - meta-analysis Feb 2022
- Low Vitamin D associated with pre-eclampsia -40th meta-analysis – Feb 2022
- Small vitamin D doses while pregnant do not decrease infant allergies – meta-analysis Feb 2022
- Anemia 1.6 X more likely during pregnancy if low Vitamin D – meta-analysis Dec 2021
- Vitamin D reduces preeclampsia, gestational diabetes and hypertension - 38th meta-analysis Dec 2021
- Need at least 6,000 IU daily while breastfeeding to eliminate Vitamin D deficiency – meta-analysis Oct 2021
- Gestational diabetes risk reduced 1.5X by Vitamin D – meta-analysis March 2021
- Gestational Diabetes – increased risk if poor Vitamin D Receptor – 2 Meta-Analyses 2021
- Small vitamin D doses given during pregnancy do not reduce childhood asthma – meta-analysis Dec 2020
- Multiple Sclerosis 40 percent more likely if mother had low vitamin D – meta-analysis Jan 2020
- Pregnancies helped by Vitamin D (insulin and birth weight in this case) – meta-analysis Oct 2019
- Preeclampsia 2.7 X less likely if 50,000 IU of Vitamin D every 2 weeks – meta-analysis Sept 2019
- Autism risk increased 30 percent by Cesareans (both low vitamin D) – meta-analysis Sept 2019
- Vitamin D treats Gestational Diabetes, decreases hospitalization and newborn complications – meta-analysis March 2019
- Birth size and weight increased by Vitamin D – meta-analysis Feb 2019
- Pregnancies helped by Vitamin D in many ways – 27th meta-analysis Jan 2019
- Vitamin D supplementation reduced SGA, fetal mortality, infant mortality – JAMA Meta – May 2018
- Gestational Diabetes 39 percent more likely if insufficient Vitamin D – Meta-analysis March 2018
- Preeclampsia reduced 2X by Vitamin D, by 5X if also add Calcium – meta-analysis Oct 2017
- Preeclampsia risk reduced 60 percent if supplement with Vitamin D (they ignored dose size) – meta-analysis Sept 2017
- Small for gestational age is 1.6 X more likely if mother was vitamin D deficient – meta-analysis Aug 2017
- Miscarriage 2 times more likely if low vitamin D – meta-analysis May 2017
- Fewer than half of pregnancies will get even 20 ng of vitamin D with 800 IU daily dose – meta-analysis May 2017
- Low Vitamin D results in adverse pregnancy and birth outcomes – Wagner meta-analysis March 2017
- Bacterial vaginosis in pregnancy increased prematurity risk by 60 percent - meta-analysis 1999
- Preterm birth rate reduced by 43 percent with adequate Vitamin D supplementation – meta-analysis Feb 2017
- Vitamin D during pregnancy reduces risk of childhood asthma by 13 percent – meta-analysis Dec 2016
- Vitamin D helps during pregnancy – meta-analysis Feb 2016
- Preterm birth 30 percent more likely if low vitamin D – meta-analysis May 2016
- Preterm birth extended by 2 weeks with Omega-3 – Meta-analysis Nov 2015
- Gestational Diabetes Mellitus 1.5X more likely if low vitamin D – meta-analysis Oct 2015
- Infant wheezing 40 percent less likely if mother supplemented with vitamin D, vitamin E, or Zinc – meta-analysis Aug 2015
- Birth weight and length increased with high levels of vitamin D – meta-analysis March 2015
- Pregnancy and Vitamin D – meta-analysis April 2015
- More vitamin D needed during pregnancy – meta-analysis Oct 2014
- Preeclampsia rate cut in half by high level of vitamin D – meta-analysis March 2014
- Preeclampsia 2.7X more frequent if low vitamin D – meta-analysis Sept 2013
- 2X more preeclampsia when vitamin D less than 30 ng, etc. - meta-analysis March 2013
- 2X more likely to have preeclampsia if less than 20 ng of vitamin D – Meta-analysis Jan 2013
- Multiple Sclerosis 23 percent more likely if born in April vs. Oct – meta-analysis Nov 2012
- Pregnancy and vitamin D meta-analysis – July 2012
- Low vitamin D increased probability of low birth weight by 60 percent – meta-analysis June 2012
- Gestational diabetes 60 percent more likely below 20 ng of vitamin D – meta-analysis Feb 2012
- Premature or low birth weight resulted in children 3X more likely to be anxious – meta-analysis May 2011
Aanchal Sablok , Aruna Batra , Achla Batra , Deeksha Joshi , Abha Aggarwal, B C Kabi3**, Harish Chellani3***
'Senior Resident, 2Professor and Head, 3Professor, *Department of Obstetrics and Gynaecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
4Scientist F, National Institute of Medical Statistics, All India Institute of Medical Sciences, New Delhi, India.
"Department of Biochemistry, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
***Department of Pediatrics, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Corresponding Author: Aanchal Sablok
Background: Vitamin D deficiency is highly prevalent in all parts of the world. Pregnant women and neonates are highly vulnerable to vitamin D deficiency.
Aim: The present study was undertaken to assess the effect of maternal 25(OH)-D status on the risk of development of preeclampsia (PE) and pre-term labour (PTL).
Materials and methods: 165 pregnant women were followed from less than 20 weeks of gestation to delivery (2015-2016) at a prenatal clinic in a tertiary care center. Development of maternal co-morbidities like pre-term labour/pre-term birth (PTL/PTB), gestational hypertension/ pre-eclampsia (GHTN/PE) and gestational diabetes mellitus (GDM) were noted. The maternal and cord blood was taken at the time of delivery and association between vitamin D concentration and the risk of development of maternal comorbidities was analyzed.
Results: Women whose 25(OH)-D levels were < 25nmol/L at delivery, 20.4% (16/83) had PTL and 24.1% (20/83) had GHTN/PE; whereas in those with levels > 50nmol/L, only 2.5% (1/37) had PTL and 2.7% (1/37) had GHTN/PE. Statistical analysis revealed that vitamin D levels >25nmol/L had a protective effect against the development of PTL (OR 0.05) and GHTN/PE (OR 0.13).
Conclusion: maternal vitamin D deficiency may be an independent risk factor for PE and PTL. Vitamin D supplementation in early pregnancy should be explored for preventing PE and PTL and for promoting neonatal well-being.
Vitamin D is not a simple vitamin but a pro-hormone, a complex molecule that plays many important roles in the body. These roles, in addition to the main function of regulating mineral salt deposition in bones, include regulation of body metabolism, mood, blood pressure and immune function.
Vitamin D is especially important during pregnancy as low maternal vitamin D stores may contribute to problems such as low birth weight and small for gestational age babies besides an increased risk of maternal comorbidities. 
Vitamin D deficiency is a worldwide epidemic, with a prevalence that ranges from 18% to 84% depending upon the country of residence, ethnicity and local clothing customs and dietary intake. [2,3] Maternal vitamin D deficiency during pregnancy has been documented in a number of studies all over the world. [4,5]
Clinical studies establishing an association between vitamin D levels and adverse pregnancy outcomes such as preeclampsia, gestational diabetes, low birth, preterm labour and caesarean delivery have conflicting results.  This is likely due to a paucity of randomized trials, heterogenicity of population studies and low sample size with poor adjustment for confounding among observational studies.
The present study was undertaken to correlate the effect of vitamin D deficiency and the risk of development of maternal and fetal co-morbidities.
MATERIALS AND METHODS
This was a prospective cohort study conducted in the department of Obstetrics and Gynaecology along with the department of Biochemistry and Neonatal division of Paediatrics at a Tertiary Care Hospital in New Delhi, India after obtaining the required clearance from the Institutional Ethics Committee.
A sample size of 165 was calculated taking 15% as the margin of error and 95% confidence limit. Primigravidae with singleton pregnancy at 18-20 weeks, willing to comply with the study protocol were included in the study between 2015 to 2016. Pregnant women with pre-existing chronic medical diseases such as hyperparathyroidism, renal, liver dysfunction, tuberculosis were excluded from the study.
At the initial visit a detailed history including symptoms of vitamin D deficiency (generalized body ache, muscular weakness), menstrual history and obstetrical history was taken. Dietary history was taken in detail based on one week recall method. Diet software (Dietsoft Vr. 1.1.7) was used to calculate the daily intake of calorie, protein and calcium intake. Vitamin D intake was calculated approximately based on vitamin D content in different food products.
Follow up was done in all patients as per the hospital protocol. Maternal co-morbidities: preeclampsia, gestational diabetes, and preterm labor, if any were recorded.
At the time of delivery, period of gestation at delivery was recorded and a complete anthropometric assessment of the neonate including: Birthweight: was recorded on electronic beam balance to the nearest 5 gm. Length: supine length was recorded to the nearest 0.1cm. Head circumference: was measured by non- stretchable fiber glass tape to the nearest 0.1cm. If caput/ moulding were present, measurement was postponed till it regressed. Signs of vitamin D deficiency in the neonate including craniotabes, condition of the fontanelles and hypocalcemic neonatal seizures were recorded.
Maternal serum and cord blood levels of 25(OH)-D using sandwich ELISA and maternal serum and cord blood calcium, phosphorus and serum ALP levels were estimated at delivery.
Women were then classified in to three groups depending upon their serum vitamin D levels at the time of delivery as sufficient: >50nmol/L, insufficient: 25-50nmol/L and deficient:<25nmol/L.
5ml of fresh maternal/cord blood was collected in vacutainers and were immediately transported to the laboratory on ice where centrifugation was done within one hour. If analysis was done within 24 hours of collection, serum was stored at 2- 8°C, otherwise the serum was stored at - 20°C until analyzed. Repeated freeze thaw cycles were avoided.
Statistical analysis was done using SPSS statistical package (version 17; SPSS). Normally distributed continuous variables were expressed as means and standard deviations, and nonparametric variables as medians and IQR. Proportions were compared using the chi square test. P values were expressed without a Bonferroni correction. Spearman’s test was used for correlations. Two- tailed significance at p<0.05 was considered significant. To find the Odd’s ratio, regression analysis was done. In running data, simple regression was used and in categorical data, logistic regression was applied.
OBSERVATION AND RESULTS
Maternal age, BMI, nutritional intake, and duration of sun exposure were associated with vitamin D levels at delivery in the total study population of 165 patients. There was no lost to follow up.
Age was found to have no effect on vitamin D levels in the body as there was a poor association between age and vitamin D levels (p > 0.05).
A very good association was seen between BMI > 25 and low 25(OH)-D levels, p = 0.001.
The regression statistics showed the OR 4.2, 95% CI (90.4- 224). Though 60% of the patients having BMI < 18.5 had vitamin D deficiency, a poor association was seen between BMI < 18.5 and vitamin D deficiency (p > 0.05).
A higher percentage of vitamin D sufficiency was seen in those with adequate daily protein (35.6%) and vitamin D (83.3%) intake compared to those with inadequate protein (15.1%) and vitamin D (12.1%) intake.
Association between the duration of sun exposure and vitamin D levels was highly significant (p = 0.000). Logistic regression showed that sun exposure has a protect effect against vitamin D deficiency with an Odd’s Ratio of 0.06, 95% CI (0.02-0.128).
The relation between pregnancy complications and 25(OH)-D levels at delivery in the total study population was analyzed. It was seen that amongst the women whose 25(OH)-D levels were <25nmol/L at delivery, 20.4% (16/83) had PTL and 24.1% (20/83) had GHTN/PE; whereas in those with levels > 50nmol/L, only 2.5% (1/37) had PTL and 2.7% (1/37) had GHTN/PE. (Table-1).
Table 1: Correlation between maternal vitamin D status and pregnancy complications.
Table 2: Correlation between the maternal and cord blood vitamin D levels.
Statistical analysis revealed that vitamin D levels >25nmol/L had a protective effect against the development of PTL (OR 0.05) and GHTN/PE (OR 0.13).
There were only two cases of GDM which were both in women with 25(OH)-D levels <50nmol/L. However, there was a poor association (p = 0.404) between the occurrence of GDM and vitamin D deficiency.
Correlation of maternal 25(OH)-D levels with cord blood 25(OH)-D levels 77% of the mothers whose serum 25(OH)-D levels were <25nmol/L were found to have neonates whose cord blood level also showed deficiency of vitamin D. Similarly 65.8% mothers whose 25(OH)-D levels were >50nmol/L had neonates with sufficient vitamin D levels. (Table 2)
Fig. 1: Correlation of Maternal Serum vitamin D at delivery with BBW.
There was a very strong positive correlation between maternal and cord 25(OH)-D levels (r = 0.915, p= 0.001)
Maternal vitamin D levels and neonatal outcome
25.6% of the babies born to mothers who were deficient in vitamin D were found to be small for gestational age where as only 3.4% of the babies born to mothers who had sufficient vitamin D levels were small for gestational age (r = 0.398, p= 0.001).(Figure 1).
Fig. 2: Correlation of Maternal Serum vitamin D with APGAR score of babies.
Apgar level <7 was seen in 14.6% of mothers having vitamin D deficiency compared to 1.3% in those who were vitamin D sufficient at delivery (p= 0.000).
A positive correlation was seen between the maternal vitamin D status and Apgar score (r= 0.325). (Figure 2).
Vitamin D is just not a simple vitamin, but a pro-hormone, a complex molecule that plays many important roles in the body. Vitamin D is especially important during pregnancy as low maternal vitamin D stores may contribute to problems such as low birth weight and small for gestational age babies besides an increased risk of maternal comorbidities. 
The mean age in the total study population in the present study was 23.48 ± 2.4 years, which was lower than the mean age (around 26 years) in a number of studies done in India and abroad. This may be because the present study included only primigravidae, while both primigravidae and multigravidae were included in other studies. [1,7,8]
On studying the total duration of the sun exposure the study subjects received and its correlation to the maternal 25 (OH)- D levels, it was found that 65.35% of the patients of the total study population were receiving less than 1 hour of sun exposure daily, irrespective of the seasonal variations throughout the year, as most of them were not allowed to work outside because of social norms and restrictions, and had clothing habits that prevented them from getting adequate sun exposure.
There was a highly significant association between the duration of sun exposure and vitamin D levels (p < 0.05). The quantum of UV-B rays (290 to 310 nm) received by an individual on exposed body surface determines the amount of vitamin D synthesized by the skin. There are similar reports of low 25(OH)--D from very hot countries of middle east, where women wear veils and levels were even lower in summers as women avoided the sun and heat by staying indoors. 
Many studies have previous concluded that circulating 25 (OH)-D concentrations were lower in obese than lean individuals10. Similar results were seen in our study with level of 25(OH)-D were lower in women with BMI > 25. This is postulated because Vitamin D metabolism is affected in obese individuals, as it is deposited in body fat stores, making it less bioavailable. 
Many clinical studies have established an association between vitamin D deficiency and higher complications during pregnancy. Vitamin D influences a number of aspects of the immune systems and may be important for infections such as bacterial vaginosis  which are responsible for PTL. Several studies have reported similar association between low 25(OH)-D levels and PTL [1,12] as was seen in the present study. More proportion of women with levels in deficient or insufficient range had PTL.
Vitamin D also has a role in immune modulation. Pre-eclampsia is thought to originate in early pregnancy when the maternal immune system limits placental invasion in mothers vulnerable to cardiovascular disease. Calcitriol an active metabolite of Vit D can be considered a pregnancy-supporting factor that could work through several mechanisms to reduce preeclampsia risk, including a direct influence of calcitriol on implantation, placental invasion and angiogenesis.  It is also believed to be important in directing immune responses by dendritic cells and macrophages at the fetal-placental interface as well as immunological adaptation by the mother to reduce the risk of infection and inflammation. 
A recent meta-analysis  has shown a consistent association between vitamin D and pre-eclampsia across different study types, supporting a role for vitamin D as a preventative agent against pre-eclampsia. The studies included in this review show conflicting results about the association of vitamin D levels and the risk of preeclampsia. However, in this review more than half of the studies showed a positive link between Vitamin D deficiencies and Preeclampsia. There is a clear need for further trials and other robust studies to identify the effect of Vitamin D on preeclampsia.
In the present study majority of the women who developed GHTN/PE had vitamin D levels in the deficient or insufficient range. Amongst the women whose 25(OH)-D levels were less than 25 nmol/L, 24% developed GTN/PE, while only 6.7% and 2.7% of women whose levels were 25-50nmol/L and >50 nmol/L developed GTN/PE respectively.
Vitamin D has been shown to influence insulin secretion and insulin resistance in a number of studies. [15,16] Vitamin D replenishment restores insulin secretion and sensitivity in patients with Type 2 diabetes with established Vitamin D deficiency, thus suggesting a role of Vitamin D in the pathogenesis of GDM. Maternal 25(OH)-D concentrations have been related to the risk of developing GDM in various cohorts. However, the present study did not show any significant association between vitamin D deficiency in mothers with GDM.
In addition, relation of fetal 25(OH)- D to neonatal outcome was studied by correlating cord blood levels to certain neonatal parameters. The parameters studied were birth weight, length, head circumference, APGAR score at 5 min and signs of calcium deficiency in neonate.
Vitamin D has been implicated in providing critical signals in gene regulation and expression in early placental development among placental trophoblast models. In endothelial cells, 1, 25-OH2- D3 has been demonstrated to increase expression of vascular endothelial growth factor (VEGF), through binding to vitamin D receptor and co-localization to a vitamin D responsive element in the VEGF promoter.  If this mechanism is also demonstrated in the placental trophoblast, it is possible that inadequate vitamin D levels may affect fetal growth through alterations in VEGF activity.
A strong correlation was noted between BBW and APGAR score with maternal vitamin D status. (fig 1 &2). A significant improvement in birth weight of infants born to vitamin D supplemented mothers has been seen in some studies [5,18] and not seen in other. 
Maternal vitamin D deficiency is a common, and potentially preventable, cause of neonatal hypocalcaemia. This is especially common in South Asian women but in the present study none of the babies in either group had any signs of calcium deficiency including craniotabes and hypocalcemic neonatal seizures.
Vitamin D deficiency is highly prevalent in all parts of the world. Pregnant women and neonates are highly vulnerable to vitamin D deficiency. Pregnant women receive very less amount of sunlight especially in parts of Southeast Asia due traditional norms and customs. Vitamin D level above 25nmol/L was found to have a protective effect against the development of PTL as well as GHTN/ PE. Also a strong positive correlation was found between maternal vitamin D levels with cord blood levels, baby’s birth weight and APGAR score. Currently, there are no guidelines on vitamin D supplementation in pregnancy in India. Thus vitamin D supplementation therapy in pregnancy can help in reducing the incidence of gestational hypertension/ preeclampsia, preterm labor/births; and have a beneficial effect on the neonates.
- Hollis BW, Donna J, Hulsey TC et al. Vitamin D supplementation during pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness. J Bone Miner Res. 2011; 26(10): 2341-2357.
- Ponsoby A.L, Lewis S and Halliday J. Vitamin D status during pregnancy and aspects of offspring health. Nutrients.2010; 2: 389-407.
- Sharma S, Ashok Kumar A, Prasad S et al. Current Scenario of Vitamin D
- Status During Pregnancy in North Indian Population. J Obst Gynecol India. 2016; 66(2), 93-100.
- Javaid MK, Crozier SR, Harvey NC. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet. 2006; 367: 36- 43.
- Sahu M, Bhatia V, Aggarwal A et al. Vitamin D deficiency in rural girls and pregnant women despite abundant sunshine in northern India. Clin Endocrinol. 2009; 70(5): 680-684.
- Morley R, Pasco A.J and Wark J.D. Maternal 25-hydroxyvitamin D and parathyroid hormone concentrations and offspring birth size. J Clin Endocrinol Metab. 2006; 91(3):906-912.
- Yu CKH, Skyes M, Sethit T et al. Vitamin D deficiency and supplementation during pregnancy. Clin Endocrinol. 2009;70: 685-690.
- Sahu M, Das V, Agarwal A et al. Vitamin D replacement in pregnant women in rural north India: a pilot study. Euro J Clin Nutr.2009; 63: 11571159.
- Al-Mohaimeed A, Zafar Khan N, Naeem Z et al. Vitamin D Status Among Women in Middle East. Journal of Health Science. 2012; 2(6): 49-56.
- Vanlint S. Vitamin D and Obesity. Nutrients 2013; 5: 949-956.
- Zhang R, Naughton DP. Vitamin D in health and disease: Current perspectives. Nutrition Journal 2010; 9: 65.
- Shibata M, Suzuki A, Sekiya T et al. High prevalence of hypovitaminosis D in pregnant Japanese women with threatened premature delivery. Jour bone miner metab.2011; 29: 615-620.
- Shin J S, Choi M Y, Longtine M S et al. Vitamin D Effects on Pregnancy and the Placenta. Placenta. 2010; 31(12): 10271034.
- Arain N, Mirza WA, Aslam M. Review- Vitamin D and the prevention of preeclampsia: A systematic review. Pak J Pharm Sci. 2015; 28(3): 1015-21.
- Kayaniyil S, Vieth R, Retnakaran R et al. Association of Vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care.2010; 33: 1379- Si.
- Pinelli NR, Jaber LA, Brown MB et al. Serum 25-Hydroxy Vitamin D and Insulin Resistance, Metabolic Syndrome, and Glucose Intolerance Among Arab Americans. Diabetes Care 2010; 33(6): 1373-1375.
- Cardus A, Parisi E, Gallego C et al. 1, 25- Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int. 2006; 69(8): 137784.
- 1S. John M. Pettifor. Vitamin D &/or calcium deficiency rickets in infants & children: a global perspective. Indian J Med Res. 2008; 127: 245-249.
- 19. Shand A, Nassar N, Von Dadelszen P et al. Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for preeclampsia. British J Obs Gynaecol. 2010;117:1593-1598.